The Cigna Group (NYSE:CI) Shares Sold by Andra AP fonden

Andra AP fonden lowered its stake in The Cigna Group (NYSE:CI - Free Report) by 19.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,800 shares of the health services provider's stock after selling 17,200 shares during the quarter. Andra AP fonden's holdings in The Cigna Group were worth $19,275,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Sterling Financial Group Inc. purchased a new stake in The Cigna Group in the 4th quarter valued at approximately $4,367,000. Principal Financial Group Inc. raised its holdings in The Cigna Group by 3.6% in the 3rd quarter. Principal Financial Group Inc. now owns 323,911 shares of the health services provider's stock valued at $112,216,000 after acquiring an additional 11,228 shares during the last quarter. Deroy & Devereaux Private Investment Counsel Inc. raised its holdings in The Cigna Group by 1.1% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 75,837 shares of the health services provider's stock valued at $20,942,000 after acquiring an additional 858 shares during the last quarter. Valley Wealth Managers Inc. raised its holdings in The Cigna Group by 2.8% in the 4th quarter. Valley Wealth Managers Inc. now owns 56,933 shares of the health services provider's stock valued at $15,721,000 after acquiring an additional 1,548 shares during the last quarter. Finally, Pine Valley Investments Ltd Liability Co raised its holdings in The Cigna Group by 28.3% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 15,713 shares of the health services provider's stock valued at $5,444,000 after acquiring an additional 3,466 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Remove Ads

Insider Buying and Selling

In other The Cigna Group news, insider Noelle K. Eder sold 9,944 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $320.00, for a total value of $3,182,080.00. Following the sale, the insider now owns 13,406 shares in the company, valued at approximately $4,289,920. This trade represents a 42.59 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 41,375 shares of company stock worth $12,866,600 over the last quarter. 0.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CI has been the subject of several analyst reports. Piper Sandler reiterated an "overweight" rating and issued a $348.00 price target (down from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Stephens cut their price target on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Truist Financial dropped their price objective on The Cigna Group from $390.00 to $375.00 and set a "buy" rating for the company in a report on Tuesday, February 4th. UBS Group dropped their price objective on The Cigna Group from $410.00 to $390.00 and set a "buy" rating for the company in a report on Monday, February 3rd. Finally, StockNews.com upgraded The Cigna Group from a "hold" rating to a "buy" rating in a report on Wednesday, February 19th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, The Cigna Group presently has an average rating of "Buy" and an average price target of $372.31.

The Cigna Group Stock Down 2.9 %

NYSE:CI traded down $9.44 on Tuesday, reaching $317.24. The stock had a trading volume of 1,955,263 shares, compared to its average volume of 1,870,027. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The company has a 50-day moving average of $294.70 and a 200 day moving average of $317.14. The stock has a market cap of $86.82 billion, a P/E ratio of 25.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the prior year, the firm posted $6.79 EPS. On average, research analysts predict that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 annualized dividend and a yield of 1.90%. The Cigna Group's dividend payout ratio is 49.35%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.